CYTEK BIOSCIENCES INC (CTKB)

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

FREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the...

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual BioTech Breakthrough Awards program. ...

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

World’s First Enhanced Small Particle (ESP™) Detection Sorter Enables Effective Content Isolation; Opens Door to Scientific Discoveries

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

Cytek has introduced the world’s first Enhanced Small Particle (ESP™) Detection Sorter, which opens the door to scientific discoveries....

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Let's have a look at the gap up and gap down stocks in today's session.

Cytek Biosciences Reports Third Quarter 2024 Financial Results

FREMONT, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis...

Which stocks are moving before the opening bell on Friday?

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024

FREMONT, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it...

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Industry Leaders to Explore Cytek’s Advanced Cell Analysis Solutions at ICCS and ESCCA

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA....

Cytek Announces Resignation of Chief Operating Officer Chris Williams

FREMONT, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced...

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Certification Emphasizes Unwavering Commitment to Quality and Is an Essential Step for U.S. Clinical Market Entry

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Cytek announced that its San Diego reagent manufacturing facility has been awarded EN ISO 13485:2016 Quality Management System (QMS) certification....

Cytek Biosciences to Participate in Upcoming Investor Conferences

FREMONT, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the...

CTKB Stock Earnings: Cytek Biosciences Misses EPS, Misses Revenue for Q2 2024

CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

Expanding Capabilities and Streamlining Experimental Workflows

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

Cytek has developed a revolutionary tool to automate panel design. SpectroPanel is an intelligent algorithm that suggests optimized panels in minutes....

Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024

FREMONT, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it...

Cytek Biosciences Announces $50 Million Stock Repurchase Program

Cytek Biosciences Announces $50 Million Stock Repurchase Program

FREMONT, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced...

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

FREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the...

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

Cytek announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received China NMPA approval for for clinical diagnostic use....

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

New Enhanced Small Particle (ESP™) Detection Option for Cytek Northern Lights™ and Cytek Aurora™ Systems Expands Capabilities of Small Particle Research

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

Cytek has announced its Enhanced Small Particle Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems....

CTKB Stock Earnings: Cytek Biosciences Misses EPS, Beats Revenue for Q1 2024

CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

CTKB Stock Earnings: Cytek Biosciences Misses EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cytek Biosciences (NASDAQ:CTKB) just reported results for the first quarter of ...

Cytek Biosciences Reports First Quarter 2024 Financial Results

Cytek Biosciences Reports First Quarter 2024 Financial Results

FREMONT, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis...

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

Company to Conduct Educational Workshops and Tutorials at CYTO and AAI’s IMMUNOLOGY2024

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

Cytek® Biosciences will spotlight its cell analysis solutions and conduct educational workshops/tutorials at CYTO and AAI's IMMUNOLOGY2024...

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

FREMONT, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it...

CTKB Stock Earnings: Cytek Biosciences Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cytek Biosciences (NASDAQ:CTKB) just reported results for the fourth quarter of...